Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosis

This study demonstrated that OAC monotherapy was associated with lower risks of composite outcome and death in patients at 1 year after ischemic stroke due to AF and atherosclerotic stenosis. In addition, the combination of an antiplatelet and OAC had a high risk of major bleeding.